<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Canadian Pharmacy Blog &#187; allergic rhinitis</title>
	<atom:link href="http://annpharmacy.com/blog/tag/allergic-rhinitis/feed" rel="self" type="application/rss+xml" />
	<link>http://annpharmacy.com/blog</link>
	<description>Health, Diseases, Drugs &#38; medications, Online canadian pharmacy</description>
	<lastBuildDate>Wed, 28 Jul 2010 16:32:20 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.1-beta1</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>SINGULAIR (Montelukast Sodium) Prevents Exercise-Induced Bronchoconstriction</title>
		<link>http://annpharmacy.com/blog/asthma/singulair-montelukast-sodium-prevents-exercise-induced-bronchoconstriction.html</link>
		<comments>http://annpharmacy.com/blog/asthma/singulair-montelukast-sodium-prevents-exercise-induced-bronchoconstriction.html#comments</comments>
		<pubDate>Sat, 02 Jan 2010 12:58:26 +0000</pubDate>
		<dc:creator>John Mitchell</dc:creator>
				<category><![CDATA[Anti-Allergic]]></category>
		<category><![CDATA[Asthma]]></category>
		<category><![CDATA[allergic rhinitis]]></category>
		<category><![CDATA[Montelukast]]></category>
		<category><![CDATA[Singulair]]></category>

		<guid isPermaLink="false">http://annpharmacy.com/blog/?p=138</guid>
		<description><![CDATA[
It has been known today that generic Singulair is effective in preventing exercise-induced bronchoconstriction (EIB). According to the update facts by Merck &#38; Co., Inc. a new indication is useful in patients aged 15 years and older.
The efficacy of SINGULAIR 10 mg was investigated in three randomized, double-blind, placebocontrolled crossover studies in 160 patients aged [...]]]></description>
		<wfw:commentRss>http://annpharmacy.com/blog/asthma/singulair-montelukast-sodium-prevents-exercise-induced-bronchoconstriction.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Final Approval For RX Cetirizine Hydrochloride Syrup ANDA</title>
		<link>http://annpharmacy.com/blog/anti-allergic/final-approval-for-rx-cetirizine-hydrochloride-syrup-anda.html</link>
		<comments>http://annpharmacy.com/blog/anti-allergic/final-approval-for-rx-cetirizine-hydrochloride-syrup-anda.html#comments</comments>
		<pubDate>Sun, 27 Dec 2009 10:42:03 +0000</pubDate>
		<dc:creator>John Mitchell</dc:creator>
				<category><![CDATA[Anti-Allergic]]></category>
		<category><![CDATA[allergic rhinitis]]></category>
		<category><![CDATA[cetirizine]]></category>

		<guid isPermaLink="false">http://annpharmacy.com/blog/?p=158</guid>
		<description><![CDATA[Abbreviated New Drug Application (ANDA) for prescription Cetirizine Hydrochloride Syrup (cetirizine syrup) is produced by a multinational, science-based pharmaceutical company, called Taro Pharmaceutical Industries Ltd. This company had received experimental approval for this ANDA in October 2007 and today it has received final approval from the U.S. Food and Drug Administration (FDA).
Generic Cetirizine syrup is [...]]]></description>
		<wfw:commentRss>http://annpharmacy.com/blog/anti-allergic/final-approval-for-rx-cetirizine-hydrochloride-syrup-anda.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Pittsburgh Study About Effectiveness Of Asthma Medication In The Common Cold</title>
		<link>http://annpharmacy.com/blog/asthma/pittsburgh-study-about-effectiveness-of-asthma-medication-in-the-common-cold.html</link>
		<comments>http://annpharmacy.com/blog/asthma/pittsburgh-study-about-effectiveness-of-asthma-medication-in-the-common-cold.html#comments</comments>
		<pubDate>Fri, 25 Dec 2009 09:49:16 +0000</pubDate>
		<dc:creator>John Mitchell</dc:creator>
				<category><![CDATA[Anti-Allergic]]></category>
		<category><![CDATA[Asthma]]></category>
		<category><![CDATA[allergic rhinitis]]></category>
		<category><![CDATA[allergy medicine]]></category>
		<category><![CDATA[Montelukast]]></category>
		<category><![CDATA[Singulair]]></category>

		<guid isPermaLink="false">http://annpharmacy.com/blog/?p=133</guid>
		<description><![CDATA[At the annual meeting of the American Academy of Allergy, Asthma and Immunology in San Diego new investigation is presented. The aim of the study conducted by physicians in the Division of Allergy, Asthma and Immunology at Allegheny General Hospital (AGH) in Pittsburgh was to reveal if Singulair (Montelukast) drug may provide relief for the [...]]]></description>
		<wfw:commentRss>http://annpharmacy.com/blog/asthma/pittsburgh-study-about-effectiveness-of-asthma-medication-in-the-common-cold.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FDA Reports About Singulair Medication</title>
		<link>http://annpharmacy.com/blog/asthma/fda-reports-about-singulair-medication.html</link>
		<comments>http://annpharmacy.com/blog/asthma/fda-reports-about-singulair-medication.html#comments</comments>
		<pubDate>Tue, 15 Dec 2009 12:41:33 +0000</pubDate>
		<dc:creator>John Mitchell</dc:creator>
				<category><![CDATA[Anti-Allergic]]></category>
		<category><![CDATA[Asthma]]></category>
		<category><![CDATA[allergic rhinitis]]></category>
		<category><![CDATA[Montelukast]]></category>
		<category><![CDATA[Singulair]]></category>

		<guid isPermaLink="false">http://annpharmacy.com/blog/?p=129</guid>
		<description><![CDATA[The US Food and Drug Administration (FDA) investigates a prescription drug Singulair (Montelukast) used in treating asthma and allergic rhinitis. It intends to reveal a potential link between the drug&#8217;s use and changes to behavior and mood, suicide, and suicidal thinking and behavior if it takes place. According to the announcement made on 27th of [...]]]></description>
		<wfw:commentRss>http://annpharmacy.com/blog/asthma/fda-reports-about-singulair-medication.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Singulair(R) Is also Indicated For Perennial Allergic Rhinitis</title>
		<link>http://annpharmacy.com/blog/asthma/singulairr-is-also-indicated-for-perennial-allergic-rhinitis.html</link>
		<comments>http://annpharmacy.com/blog/asthma/singulairr-is-also-indicated-for-perennial-allergic-rhinitis.html#comments</comments>
		<pubDate>Fri, 04 Dec 2009 10:32:03 +0000</pubDate>
		<dc:creator>John Mitchell</dc:creator>
				<category><![CDATA[Anti-Allergic]]></category>
		<category><![CDATA[Asthma]]></category>
		<category><![CDATA[allergic rhinitis]]></category>
		<category><![CDATA[Montelukast]]></category>
		<category><![CDATA[SAR]]></category>
		<category><![CDATA[Singulair]]></category>

		<guid isPermaLink="false">http://annpharmacy.com/blog/?p=125</guid>
		<description><![CDATA[It has been proven that taking Singulair tablets once a day help relieve a variety of indoor and  outdoor allergy symptoms for up to 24 hours.
Gailen Marshall Jr., M.D., Ph.D., director of the  Division of Clinical Immunology and Allergy at the University of Mississippi  Medical Center in Jackson, MS,  considers allergic [...]]]></description>
		<wfw:commentRss>http://annpharmacy.com/blog/asthma/singulairr-is-also-indicated-for-perennial-allergic-rhinitis.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>New Formulation Of Zyrtec Medication For Young Patients</title>
		<link>http://annpharmacy.com/blog/anti-allergic/new-formulation-of-zyrtec-medication-for-young-patients.html</link>
		<comments>http://annpharmacy.com/blog/anti-allergic/new-formulation-of-zyrtec-medication-for-young-patients.html#comments</comments>
		<pubDate>Sun, 29 Nov 2009 14:18:15 +0000</pubDate>
		<dc:creator>John Mitchell</dc:creator>
				<category><![CDATA[Anti-Allergic]]></category>
		<category><![CDATA[allergic rhinitis]]></category>
		<category><![CDATA[allergy medicine]]></category>
		<category><![CDATA[Asthma]]></category>
		<category><![CDATA[cetirizine]]></category>
		<category><![CDATA[Zyrtec]]></category>

		<guid isPermaLink="false">http://annpharmacy.com/blog/?p=147</guid>
		<description><![CDATA[Today it has been known that New   York (USA)  Pfizer Inc and UCB Pharma confirmed a new chewable formulation of Zyrtec drug (cetirizine HCl).
Cetirizine allergy medication is considered to be the  number-one prescribed antihistamine by pediatricians and allergists for the  treatment of seasonal and perennial allergic  rhinitis (inflammation of [...]]]></description>
		<wfw:commentRss>http://annpharmacy.com/blog/anti-allergic/new-formulation-of-zyrtec-medication-for-young-patients.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The Updated Information About SINGULAIR DRUG and other Leukotriene Inhibitors</title>
		<link>http://annpharmacy.com/blog/asthma/the-updated-information-about-singulair-drug-and-other-leukotriene-inhibitors.html</link>
		<comments>http://annpharmacy.com/blog/asthma/the-updated-information-about-singulair-drug-and-other-leukotriene-inhibitors.html#comments</comments>
		<pubDate>Mon, 16 Nov 2009 13:56:27 +0000</pubDate>
		<dc:creator>John Mitchell</dc:creator>
				<category><![CDATA[Asthma]]></category>
		<category><![CDATA[allergic rhinitis]]></category>
		<category><![CDATA[Montelukast]]></category>
		<category><![CDATA[PAR]]></category>
		<category><![CDATA[SAR]]></category>
		<category><![CDATA[Singulair]]></category>

		<guid isPermaLink="false">http://annpharmacy.com/blog/?p=117</guid>
		<description><![CDATA[Singulair (Montelukast) was introduced in 1998. Generic Singulair is indicated for the patients on asthma aged from children of 12 months and older. This Asthma medicine is used for the relief of symptoms of seasonal allergic rhinitis (SAR) in adults and children 2 years and older, and for the relief of symptoms of perennial allergic [...]]]></description>
		<wfw:commentRss>http://annpharmacy.com/blog/asthma/the-updated-information-about-singulair-drug-and-other-leukotriene-inhibitors.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
